Global Coalition of TB Activists lends voice to international discourse

"The Global Coalition of TB Activists [GCTA] came together at a February Stop TB Partnership meeting in Geneva, [an] announcement says, with the aim of closing gaps that leave those most affected by tuberculosis out of decision making at local, national, and global levels," the Center for Global Health Policy's "Science Speaks" blog reports. "The formation of an internationally based coalition will help involve those individuals and communities 'in a global, strategic and integrated way,' Alberto Colorado, [a sociologist, patient advocate and international public health consultant,] told Science Speaks," the blog writes. "The announcement of the GCTA's launch included statements from Global Fund to Fight AIDS, Tuberculosis and Malaria Executive Director Mark Dybul and Stop TB Partnership Executive Secretary Lucica Ditiu, welcoming the creation of the group," the blog notes, adding, "The GCTA is inviting TB patients and survivors, members of affected communities and TB activists working across the world to join the coalition through its Google Group" (Barton, 3/28).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Novel anti-tuberculosis compound targets bacterial membrane protein